Cardiovascular Systems reported $49.26M in Gross Profit on Sales for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6055M 182M
Abiomed ABMD:US $ 195.17M 4.62M
Atricure ATRC:US $ 44.54M 2.1M
Baxter International BAX:US $ 1165M 54M
Becton, Dickinson and BDX:US $ 2246M 486M
Boston Scientific BSX:US $ 1846M 150M
Cardiovascular Systems CSII:US $ 49.26M 0.99M
Dexcom DXCM:US $ 343.9M 66.4M
Edwards Lifesciences EW:US $ 923.2M 27.8M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Globus Medical GMED:US $ 172.32M 269K
Hologic HOLX:US $ 1085.8M 94.6M
Inogen INGN:US $ 39.87M 5.81M
Insulet PODD:US $ 167.5M 6.4M
Intuitive Surgical ISRG:US $ 902.6M 6.8M
Johnson & Johnson JNJ:US $ 15285M 593M
Medtronic MDT:US $ 5587M 397M
Merit Medical Systems MMSI:US $ 111.89M 0.73M
Nuvasive NUVA:US $ 199.44M 7.74M
Resmed RMD:US $ 447.26M 15.22M
Stryker SYK:US $ 2431M 342M
Tandem Diabetes Care TNDM:US $ 73.29M 17.27M
Teleflex TFX:US $ 344.53M 39.03M
Terumo 4543:JP Y 85355M 5449M